Swiss National Bank’s Olema Pharmaceuticals OLMA Stock Holding History

Swiss National Bank’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Buy	+74,600	New	+$1.66M	﹤0.01%	2115
2025 Q1	–	Sell	-66,000	Closed	-$385K	–	2438
2024 Q4	$385K	Hold	66,000	–	–	﹤0.01%	2422
2024 Q3	$788K	Hold	66,000	–	–	﹤0.01%	2316
2024 Q2	$714K	Sell	66,000 -4,300	-6%	-$46.6K	﹤0.01%	2314
2024 Q1	$796K	Buy	70,300 +5,700	+9%	+$73.5K	﹤0.01%	2323
2023 Q4	$906K	Buy	+64,600	New	+$868K	﹤0.01%	2295
2022 Q2	–	Sell	-21,800	Closed	-$93K	–	2774
2022 Q1	$93K	Hold	21,800	–	–	﹤0.01%	2689
2021 Q4	$204K	Buy	+21,800	New	+$452K	﹤0.01%	2717

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Swiss National Bank's OLMA Position: Q1 2026 in Review

Swiss National Bank opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 74,600 shares worth $1.11M. The stake represents ﹤0.01% of the portfolio and ranks #2115 among its holdings. This is a return to the name: Swiss National Bank previously reported a position in OLMA as recently as Q4 2024.

Swiss National Bank first reported a position in OLMA in Q4 2021 and has held it in 8 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Swiss National Bank held 74,600 shares of Olema Pharmaceuticals worth $1.11M as of Q1 2026.
Olema Pharmaceuticals was a new Swiss National Bank position in Q1 2026.
Olema Pharmaceuticals made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2115 holding.
Swiss National Bank first reported a position in Olema Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.